TheFly.com
Start Free Trial
<
Back to all Breaking News
PFE, LLY
4/18/2019 17:04pm
8
Street Research Stories
9
Calendar Events
chevron_right
Pfizer, Lilly say tanezumab met 2/3 co-primary endpoints in Phase 3 study
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.
Join Now
Learn More
Already have an account?
Sign In Here
Subscription Rates
dynamic_feed
Breaking News
search
Search
menu
Menu
